Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Abikoff, C. A., Nash, M., Nickerson, B., Harrison, L., Shi, Q., Zhang, X., . . . Cairo, M. S. (2016). A pilot study of unrelated cord blood (UCB) transplantation followed by unmatched human placental derived stem cells (HPDSC) in children and young adults with malignant and non-malignant diseases. Pediatric Blood & Cancer, 63(Suppl S1), S96. doi:10.1002/pbc.25998
Abikoff, C. M. & Cairo, M. S. (2014). Reduced intensity conditioning and hematopoietic stem cell transplantation in pediatric nonmalignant disease: A new therapeutic paradigm. The Journal of Pediatrics, 164(5), 952-953.e2. doi:10.1016/j.jpeds.2014.01.061
Abikoff, C. M., Shi, Q., Giller, R., Pulsipher, M. A., Szabolcs, P., Hochberg, J., . . . Cairo, M. S. (2014). A pilot study of unrelated cord blood (UCB) transplantation and unmatched human placental derived stem cells (HPDSC) in pediatric malignant and non-malignant disease. Biology of Blood and Marrow Transplantation, 20(2), S137-138. doi:10.1016/j.bbmt.2013.12.211
Abou Jaoude, R., Zauk, A., Morel, C., McClure, D., Lamacchia, M., & DeBari, V. A. (2014). Fluconazole prophylaxis is associated with a decreased rate of coagulase-negative staphylococcal infections in a subset of extremely low birth weight neonates. Medical Microbiology and Immunology, 203(4), 251-256. doi:10.1007/s00430-014-0337-2
Annunziato, R. A., Parbhakar, M., Kapoor, K., Matloff, R., Casey, N., Benchimol, C., . . . Hotchkiss, H. (2015). Can transition to adult care for transplant recipients be improved by intensified services while patients are still in pediatrics? Progress in Transplantation, 25(3), 236-242. doi:10.7182/pit2015599
Arawiran, J., Curry, J., Welde, L., & Alpan, G. (2015). Sojourn in excessively high oxygen saturation ranges in individual, very low-birthweight neonates. Acta Paediatrica, 104(2), e51-e56. doi:10.1111/apa.12827
Arora, M., Hemmer, M. T., Ahn, K. W., Klein, J. P., Cutler, C. S., Urbano-Ispizua, A., . . . Cairo, M. S. (2015). Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. Biology of Blood and Marrow Transplantation, 21(4), 640-645. doi:10.1016/j.bbmt.2014.10.022
Awasthi, A., Ayello, J., van de Ven, C., Chakraborty, S., Barth, M., & Cairo, M. (2016). Polatuzumab vedotin (PV, ANTI-CD79B-VC-MMAE) significantly increased apoptosis/reduced cell proliferation and improved survival against Burkitt lymphoma (BL) and primary mediastinal large B-cell lymphoma (PMBL). Pediatric Blood & Cancer, 63(Suppl 3), S208. This material can be found here.
Awasthi, A., Ayello, J., van de Ven, C., Love, A. C., & Cairo, M. S. (2016). Polatuzumab vedotin; antibody drug conjugates (ADC, anti-CD79b-vc-MMAE, PV) significantly enhances in-vitro cell death against CD79b+ Burkitt lymphoma (BL) /primary mediastinal large B cell lymphoma (PMBL) and improved overall survival against rituximab sensitive/resistant-BL NSG xenograft mice. Blood, 128(22), 4126. This material can be found here.
Ayello, J., Chu, Y., Keever-Taylor, C. A., Talano, J. A., Weinberg, R., Abikoff, C. M.,. . . Cairo, M. S. (2016). A pilot trial of unmatched human placenta-derived stem cells (HPDSCs) in conjunction with unrelated cord blood transplantation (UCBT) in children and young adults with malignant and non-malignant disease (IND 14949). Blood, 128(22), 4671.
Ayello, J., Chu, Y., Keever-Taylor, C. A., Talano, J. A., Weinberg, R., Abikoff, C. M., . . . Cairo, M. S. (2016). Familial haploidentical (FHI) allogeneic stem cell transplantation utilizing CD34 enrichment and T cell addback in children, adolescents & adults with high-risk sickle cell disease. Rapid engraftment, low incidence of AGVHD, and sustained donor chimerism. Blood, 128(22), 1245.
Ayello, J., Keever-Taylor, C., Weinberg, R., Grossman, B. J., Shenoy, S., Talano, J. X., . . . Cairo, M. (2016). Processing of G-CSF mobilized peripheral blood stem cells (PBSC) from parental haploidentical sickle cell trait donors undergoing CD34 enrichment with T cell addback in children, adolescents and adults with high risk sickle cell disease (IND 14359). Transfusion, 56(S4), 5A.
Bachanova, V., Burns, L. J., Ahn, K. W., Laport, G. G., Akpek, G., Kharfan-Dabaja, M. A., . . . Cairo, M. (2015). Impact of pretransplantation F-fluorodeoxy glucose-positron emission tomography status on outcomes after allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. Biology of Blood and Marrow Transplantation, 21(9), 1605-1611. doi:10.1016/j.bbmt.2015.05.007
Bachanova, V., Burns, L. J., Wang, T., Carreras, J., Gale, R. P., Wiernik, P. H., . . . Cairo, M. S. (2015). Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor. Bone Marrow Transplantation, 50(2), 197-203. doi:10.1038/bmt.2014.259
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler Jr., V. G., Tleyjeh, I. M., Rybak, M. J., . . . Gewitz, M. H. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation, 132(15), 1435-1486. doi:10.1161/CIR.0000000000000296
Ballabh, P. (2014). Oligodendrocyte progenitors and brain remodeling following blood-brain barrier rupture. In M. Junier, & S. Kernie (Eds.), Endogenous stem cell-based brain remodeling in mammals (pp. 159-175). New York: Humana.
Ballabh, P. (2014). Pathogenesis and prevention of intraventricular hemorrhage. Clinics in Perinatology, 41(1), 47-67. doi:10.1016/j.clp.2013.09.007
Ballabh, P., & Back, S. A. (2014). Advances in neonatal neurology. Clinics in Perinatology, 41(1), xvii-xix. doi:10.1016/j.clp.2013.11.002
Ballabh, P., & La Gamma, E. F. (2014). Strategies for working with a preterm rabbit model of glycerol-induced intraventricular hemorrhage: Strengths and limitations. Pediatric Research, 76(5), 495-496. doi:10.1038/pr.2014.111
Baltimore, R. S., Gewitz, M., Baddour, L. M., Beerman, L. B., Jackson, M. A., Lockhart, P. B., . . . Pahl, E. Infective endocarditis in childhood: 2015 update: A scientific statement from the American Heart Association. Circulation, 132(15), 1487-1515. doi:10.1161/CIR.0000000000000298
Bamji, N., Berezin, S., Bostwick, H., & Medow, M. S. (2015). Treatment of Sandifer syndrome with an amino-acid-based formula. AJP Reports, 5(1), e51-e52. doi:10.1055/s-0035-1545672
Banka, P., Robinson, J. D., Uppu, S. C., Harris, M. A., Hasbani, K., Lai, W. W., S. . . . Jain, S. (2015). Cardiovascular magnetic resonance techniques and findings in children with myocarditis: A multicenter retrospective study. Journal of Cardiovascular Magnetic Resonance, 17(1), 96. doi:10.1186/s12968-015-0201-6
Barth, M., Goldman, S., Oesterheld, J., Heym, K., Harrison, L., Nickerson, B., & Cairo, M. (2016). Preliminary results of the Reduced Burden of Oncologic Therapy (Reboot) trial in children, adolescents and young adults with intermediate and high risk aggressive B-cell non Hodgkin lymphoma. Pediatric Blood & Cancer, 63(Suppl S1), S16.
Barth, M. J., Chu, Y., Hanley, P. J., & Cairo, M. S. (2016). Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma. British Journal of Haematology, 173(4), 597-616. doi:10.1111/bjh.14078
Barth, M. J., Goldman, S., Smith, L., Perkins, S., Shiramizu, B., Gross, T. G., . . . Cairo, M. S. (2013). Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: A Children's Oncology Group report. British Journal of Haematology, 162(5), 678-683. doi:10.1111/bjh.12434
